loteprednol etabonate 0.0038 MG/MG Ophthalmic Gel [Lotemax]
- RxCUI
- 2118539
- RxNorm name
- loteprednol etabonate 0.0038 MG/MG Ophthalmic Gel [Lotemax]
- Display name
- loteprednol etabonate 0.0038 MG/MG Ophthalmic Gel [Lotemax]
- Full name
- loteprednol etabonate 0.0038 MG/MG Ophthalmic Gel [Lotemax]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:03
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lotemax SM | LOTEPREDNOL ETABONATE | Bausch & Lomb Incorporated | 6f9477b5-699f-4d3b-b9a6-0cc238266237 | 2026-03-31 | Warnings, Adverse reactions | 2118539 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 6f9477b5-699f-4d3b-b9a6-0cc238266237 | LOTEMAX SM 0.38 % Ophthalmic Gel [PSN] · loteprednol etabonate 0.0038 MG/MG Ophthalmic Gel [Lotemax] [SBD] · Lotemax 0.0038 MG/MG Ophthalmic Gel [SY] · Lotemax 0.38 % Ophthalmic Gel [SY] | 4 | 5 | These highlights do not include all the information needed to use LOTEMAX ® SM safely and effectively. See full prescribing information for LOTEMAX ® SM. LOTEMAX ® SM (loteprednol etabonate ophthalmic gel), for topical ophthalmic use Initial U.S. Approval: 1998 | 20260331 |